Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
47
Number of overlapping holdings
56.0%
% of WDNA's 90 holdings also in IBB
21.1%
% of IBB's 260 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in WDNA |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
NATERA INC | 3.7% | 2.3% | 2.3% |
|
GILEAD SCIENCES INC | 1.9% | 8.6% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 9.6% | 1.8% |
|
AMGEN INC | 1.7% | 8.4% | 1.7% |
|
ALNYLAM PHARMACEUTICALS INC | 1.6% | 3.5% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to IBB
|
TWIST BIOSCIENCE CORP. | 3.0% |
 |
NOVOZYMES A/S-B SHARES | 2.9% |
|
ELI LILLY & CO | 2.7% |
|
VERICEL CORPORATION | 2.3% |
|
BLUEPRINT MEDICINES CORP. | 1.9% |
|
VERACYTE INC | 1.8% |
|
BRIDGEBIO PHARMA, INC. | 1.8% |
|
AGIOS PHARMACEUTICALS INC | 1.7% |
 |
NOVARTIS AG | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 1.5% |
WDNA Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -7.7% |
|
AMGEN INC | -6.8% |
|
GILEAD SCIENCES INC | -6.7% |
|
REGENERON PHARMACEUTICALS | -6.1% |
|
IQVIA HOLDINGS INC | -3.1% |
|
METTLER-TOLEDO INTERNATIONAL | -2.5% |
|
WATERS CORP | -2.3% |
 |
ARGENX SE ADR | -2.1% |
|
ALNYLAM PHARMACEUTICALS INC | -1.9% |
|
INSMED INC | -1.6% |